跳至主要内容
临床试验/NCT00607529
NCT00607529已完成不适用

Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device

Memorial Sloan Kettering Cancer Center1 个研究点 分布在 1 个国家目标入组 99 人开始时间: 2007年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
99
试验地点
1
主要终点
The primary outcomes would be, reduced wait time and increased patient satisfaction.

研究概览

简要总结

This study is being done to see if the Nova Creatinine Meter can give a correct measure of creatinine (a blood test used to measure kidney function) when the blood is taken from a capillary (smallest type of blood vessels). The Nova Creatinine Meter is a hand held device that can be used in a clinic to measure creatinine in about 50 seconds. Current laboratory creatinine testing can take up to an hour. Since chemotherapy patients need to have their creatinine measured prior to treatment, this meter could make testing easier and faster.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written Informed Consent
  • Must have a creatinine > or = to than 3.5 mg/dl

排除标准

  • Patients who are less than 18 years of age

结局指标

主要结局

The primary outcomes would be, reduced wait time and increased patient satisfaction.

时间窗: conclusion of the study

次要结局

  • reduced blood loss(conclusion of the study)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验